1.
ERJ Open Res
; 10(4)2024 Jul.
Artículo
en Inglés
| MEDLINE
| ID: mdl-39040583
RESUMEN
Dupilumab has been associated with adverse reactions including symptomatic hypereosinophilia. This study reports the incidence of dupilumab-related eosinophilia and adverse reactions in severe asthma patients at an Australian tertiary centre. https://bit.ly/3JgZ5Ya.